Skip to main content
Trials test Cosentyx against Humira and biosimilar
1/12/2018

Novartis is conducting two trials comparing Cosentyx, or secukinumab, with AbbVie's Humira and Novartis' own biosimilar. Cosentyx is approved for treating plaque psoriasis, ankylosing spondylitis and psoriatic arthritis.

Full Story: